BYSI Stock Analysis: Buy, Sell, or Hold?
BYSI - BeyondSpring Inc. Ordinary Shares
$0.76
0.00 (-0.37%)
âŧ
5d:
+22.79%
30d:
+2.96%
90d:
-53.7%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 12, 2026
0d
Get Alerted When BYSI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: BYSI is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: BYSI is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: BYSI is currently trading at $0.76, which is considered fair relative to its 30-day fair value range of $0.62 to $0.89.
Technical Outlook: Technically, BYSI is in a strong downtrend. Immediate support is located at $0.60, while resistance sits at $0.79.
Market Sentiment: BYSI scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $1.25 (+63.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BYSI is in a strong downtrend. Immediate support is located at $0.60, while resistance sits at $0.79.
Market Sentiment: BYSI scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $1.25 (+63.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.62 -
$0.89
Company Quality Score
41/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
44.7%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (30/100)
- BULLISH: Trading 63.6% below Wall St target ($1.25)
- WARNING: Composite score 41/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.62 -
$0.89
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.60
Resistance Level
$0.79
Current Trend
Strong Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.54
Wall Street Target
$1.25
(+63.6%)
Revenue Growth (YoY)
14.3%
Share & Embed Analysis
Last updated: September 14, 2026 9:11 AM ET
Data refreshes hourly during market hours. Next update: 10:11 AM
Data refreshes hourly during market hours. Next update: 10:11 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BYSI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals âĻ |
STRONG BUY
30 analysts |
$371 | 43 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$432 | 48 HOLD |
|
VRTX
Vertex Pharmaceuticals IâĻ |
BUY
34 analysts |
$569 | 38 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$314 | 47 HOLD |
|
RYTM
Rhythm Pharmaceuticals IâĻ |
STRONG BUY
12 analysts |
$140 | 62 BUY |
